Alembic Ltd.
BSE: 506235 | Sector: Health care |
NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
BSE 00:00 | 01 Mar | 101.50 |
-0.25 (-0.25%) |
OPEN
103.80 |
HIGH
103.80 |
LOW
101.15 |
NSE 00:00 | 01 Mar | 101.60 |
-0.15 (-0.15%) |
OPEN
103.40 |
HIGH
103.40 |
LOW
101.00 |
OPEN | 103.80 |
PREVIOUS CLOSE | 101.75 |
VOLUME | 22994 |
52-Week high | 122.75 |
52-Week low | 25.00 |
P/E | 39.96 |
Mkt Cap.(Rs cr) | 2,607 |
Buy Price | 101.50 |
Buy Qty | 300.00 |
Sell Price | 102.00 |
Sell Qty | 90.00 |
About Alembic Ltd.
Alembic Ltd is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. They are the first pharmaceutical company in India to cross 100 years of operations. They are in the business of improving the quality of life and healthcare in over 75 countries around the world.The company is a ISO-9002 and ISO-14001 certified company with...> More
Alembic Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
2,607 | |
EPS - TTM | (![]() |
[*S] | 2.54 |
P/E Ratio | (X) | [*S] | 39.96 |
Face Value | (![]() |
2 | |
Latest Dividend | (%) | 30.00 | |
Latest Dividend Date | 29 Jul 2020 | ||
Dividend Yield | (%) | 0.59 | |
Book Value / Share | (![]() |
[*S] | 22.95 |
P/B Ratio | (![]() |
[*S] | 4.42 |
Announcement
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Alembic Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 14.48 | 12.76 | 13.48 |
Other Income | 3.02 | 2.06 | 46.6 |
Total Income | 17.5 | 14.82 | 18.08 |
Total Expenses | 10.58 | 12.88 | -17.86 |
Operating Profit | 6.92 | 1.94 | 256.7 |
Net Profit | 4.87 | 0.92 | 429.35 |
Equity Capital | 51.36 | 51.36 | - |
Alembic Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Shilpa Medicare | 367.20 | -0.50 | 2992.68 |
Indoco Remedies | 297.35 | 1.88 | 2740.08 |
Neuland Labs. | 2053.20 | 1.22 | 2634.26 |
Alembic | 101.50 | -0.25 | 2606.52 |
Marksans Pharma | 56.10 | 1.26 | 2296.17 |
Unichem Labs. | 322.30 | -3.82 | 2268.99 |
Hikal | 159.90 | 0.60 | 1971.57 |
Alembic Ltd - SHAREHOLDING PATTERN
|
|
Alembic Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 1.30% | 1.35% | 0.21% | 0.58% |
1 Month | 5.67% | 6.11% | 2.57% | 3.36% |
3 Month | -3.52% | -3.51% | 11.63% | 12.61% |
6 Month | 15.93% | 16.25% | 28.15% | 28.69% |
1 Year | 110.58% | 111.23% | 30.17% | 31.78% |
3 Year | 100.87% | 99.80% | 46.42% | 41.15% |
Alembic Ltd - STOCK STRENGTH
Today's Low/High | 101.15 | 103.80 | |
Week Low/High | 100.00 | 107.00 | |
Month Low/High | 92.90 | 108.00 | |
YEAR Low/High | 25.00 | 123.00 | |
All TIME Low/High | 1.04 | 123.00 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices